Association between high sensitivity cardiac troponin and mortality risk in the non-diabetic population: findings from the National Health and Nutrition Examination Survey

Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT

(2022) Simon B. Ascher et al.   Journal of the American Heart Association

Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes

(2021) Marco Witkowski et al.   Cardiovascular Diabetology

Screening for Prediabetes and Type 2 Diabetes

(2021) Daniel E. Jonas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering

(2021) Jarett D. Berry et al.   JAMA Cardiology

2020 International Society of Hypertension Global Hypertension Practice Guidelines

(2020) Thomas Unger et al.   HYPERTENSION

High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study

(2020) Junichi Ishigami et al.   CLINICAL CHEMISTRY

Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: Results from the Tohoku Medical Megabank Project

(2019) Yuji Takahashi et al.   BIOMARKERS

Cardiac Troponin T and Troponin I in the General Population

(2019) Paul Welsh et al.   CIRCULATION

Prediabetes and Cardiovascular Disease

(2018) Ben Brannick et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

The prognostic value of troponin T and N‐terminal pro B‐type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes

(2018) Rasmus Rørth et al.   EUROPEAN JOURNAL OF HEART FAILURE

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study

(2016) Seamus P. Whelton et al.   DIABETES CARE

Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications

(2016) Ben Brannick et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease

(2016) Ian Ford et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study

(2015) Kristian B. Filion et al.   AMERICAN HEART JOURNAL

β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment

(2014) Philippe A. Halban et al.   DIABETES CARE

Macrovascular complication phenotypes in type 2 diabetic patients

(2013) Giuseppe Papa et al.   Cardiovascular Diabetology

Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus

(2011) Brendan M. Everett et al.   CIRCULATION

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

(2011) Justin T. Saunders et al.   CIRCULATION

Standards of Medical Care in Diabetes--2010

(2009)   DIABETES CARE

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

(2009)   DIABETES CARE

Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose

(2009) Samuel Dagogo-Jack et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE